The drug pric­ing de­bate in Amer­i­ca reach­es a boil­ing point at #JPM19

On stage: John Car­roll, Christi Shaw (Lil­ly), Pe­ter Bach (MSKCC), Kath­leen Tre­go­ning (Sanofi), Stephen Ubl (PhRMA), Jef­frey Mar­raz­zo (Spark)

End­points News or­ga­nized a pan­el dis­cus­sion in San Fran­cis­co dur­ing JP­Mor­gan in ear­ly Jan­u­ary de­vot­ed to one of the hottest dis­cus­sions in the in­dus­try: drug pric­ing. No mat­ter how this plays out, drug pric­ing af­fects every­one who has an in­ter­est in bio­phar­ma, re­gard­less of the po­si­tion they hold.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER